Dr Lal PathLabs Q4 Earnings: Net profit falls 7.5% YoY to ₹56.7 crore; declares dividend of ₹6 per share
Dr Lal PathLabs' revenue from operations during Q4FY23 increased marginally by 1.1% to ₹491 crore from ₹485.5 crore, YoY.
PremiumDr Lal PathLabs reported a net profit of ₹56.7 crore in the quarter ended March 2023, registering a fall of 7.5% from ₹61.3 crore in the corresponding quarter of last year.
The company’s revenue from operations during Q4FY23 increased marginally by 1.1% to ₹491 crore from ₹485.5 crore, YoY. Non-Covid revenue rose by 14.4% in Q4 FY23 & 15.5% in FY23.
On the operating front, earnings before interest, depreciation and amortization (EBITDA) decreased 4.5% to ₹115.6 crore from ₹121.1 crore, while EBITDA margin also contracted by 140 bps to 23.5% from 24.9%.
The board of directors of the company also recommended a final dividend of ₹6 per equity share, which is 60% of the face value of ₹10 per share, for the year ended March 31, 2023, subject to approval of the shareholders.
For the financial year 2022-2023, Dr Lal PathLabs’ revenue from operations stood at ₹2,016.9 crore, down 3.3% from ₹2,087.4 crore in FY 2021-2022.
Its net profit for the year also declined by 30.7% to ₹238.9 crore from ₹344.8 crore in FY22.
At 2:25pm, the shares of Dr Lal PathLabs were trading 2.25% lower at ₹1,905.95 a piece on the BSE.
Catch Live Market Updates here
"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!
